Cizzle Biotechnology Holdings Plc.

Cizzle Biotech was initially funded by Yorkshire Cancer Research, White Rose Technology Seed Corn Fund, Finance Yorkshire Seedcorn LLP and Viking Members, who with management, invested in the project to support the development of a prototype blood test. Enabling faster treatment with early lung cancer detection to save lives.